Kidney Failure News and Research

RSS

Study shows that while the rate of high blood pressure increased with age, numbers of people receiving treatment for the condition did not

Nearly two-thirds of men and women age 80 and older have high blood pressure, but their conditions are frequently not kept under control, according to new data from the National Heart, Lung, and Blood Institute's (NHLBI) long-standing Framingham Heart Study.

26 Jul 2005

GenoMed submits 50th provisional patent application

GenoMed announced today that the Company has submitted its 50th provisional patent application, a major milestone in any development stage company. GenoMed has so far been awarded two patents, one for treating acute kidney failure without dialysis, and another for hastening lung maturation in prematurely born infants.

26 Jul 2005

Metformin should be in the first line of defense against type 2 diabetes

A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes. Using metformin alone can improve control of blood glucose, while also reducing risk factors for heart disease such as excess body weight, cholesterol levels and hypertension, the review found.

20 Jul 2005

ACE inhibitors should be available at no cost to the 8 million Americans over age 65 who have diabetes

Nothing in life is free, the old saying goes. But maybe some things should be, according to a new University of Michigan Health System study.

18 Jul 2005

New treatment option for bad breath

More than 90 million Americans can sigh comfortably because of new relief for their bad breath. Dental experts today revealed research highlighting a new treatment option that can eliminate halitosis or chronic bad breath at the Academy of General Dentistry's (AGD) 53rd Annual Meeting in Washington, D.C.

18 Jul 2005

High blood pressure reduces life expectancy

New research has found that the impact of high blood pressure on life expectancy may be far more significant than previously thought.

29 Jun 2005

Yet another proven benefit of tight glucose control for those with type 1 diabetes

New study results confirm, for the first time, that intensive treatment of diabetic patients results in a significantly lower risk of heart disease. In fact, it can cut the risk of cardiovascular disease nearly in half.

16 Jun 2005

GenoMed to be awarded new patent, for treating acute kidney failure without dialysis

GenoMed announced today that the US Patent Office has allowed claims and will be following up with an issued patent shortly on the Company's protocol to treat acute kidney failure with a drug rather than the dialysis machine.

14 Jun 2005

Fewer diabetics end up in hospital

According to new research from the U.S. Centers for Disease Control and Prevention (CDC), Americans with diabetes are less likely than they were a decade ago, to need hospitalization for serious complications such as kidney failure.

14 Jun 2005

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Eli Lilly and Company today announced encouraging results from a one-year pilot study examining the effect of ruboxistaurin mesylate in persons with type 2 diabetes and kidney disease (also known as "diabetic nephropathy").

12 Jun 2005

Link between PKC enzyme and kidney disease in diabetes confirmed

Researchers at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.

12 Jun 2005

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Scientists at Joslin Diabetes Center have investigated PKC-beta -- a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes -- for more than two decades.

10 Jun 2005

Rheumatoid arthritis costs more to business and industry than almost any other disease

Speaking at a rheumatology congress in Vienna today (Thursday 9 June), USA experts estimated that RA costs employers over $4,000 more per person, per year.

9 Jun 2005

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

A Davidson woman has been successfully treated for her Type 1 diabetes through a procedure performed at Carolinas Medical Center. Paul F. Gores, M.D., has led a multi-disciplinary team through a series of three pancreatic islet cell transplants since the summer of 2003. The result is a patient who is now insulin-free.

8 Jun 2005

La Jolla Pharmaceutical provides update on Riquent

La Jolla Pharmaceutical Company today announced that it has received "fast track" designation for Riquent (abetimus sodium) for the treatment of lupus renal disease from the U.S. Food and Drug Administration (FDA).

31 May 2005

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

A post-market analysis of cholesterol-lowering drugs called statins indicates that some of the most serious side effects may be higher in one of the newest drugs, rosuvastatin (Crestor). The drug is the strongest statin available because it has the greatest effect per milligram on low-density lipoprotein ("bad" cholesterol).

26 May 2005

Kidney Failure News and Research

Study shows that while the rate of high blood pressure increased with age, numbers of people receiving treatment for the condition did not

GenoMed submits 50th provisional patent application

Metformin should be in the first line of defense against type 2 diabetes

ACE inhibitors should be available at no cost to the 8 million Americans over age 65 who have diabetes

New treatment option for bad breath

High blood pressure reduces life expectancy

Yet another proven benefit of tight glucose control for those with type 1 diabetes

GenoMed to be awarded new patent, for treating acute kidney failure without dialysis

Fewer diabetics end up in hospital

Tight glucose control lowers CVD by about 50 percent in diabetes

Ruboxistaurin shows favorable effects on kidney damage and function in people with type 2 diabetes and nephropathy

Link between PKC enzyme and kidney disease in diabetes confirmed

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Rheumatoid arthritis costs more to business and industry than almost any other disease

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

La Jolla Pharmaceutical provides update on Riquent

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

New cholesterol drug Crestor causes safety concerns

Two out of three Americans with type-2 diabetes do not have their disease under control

Research proves the dangers of salt

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News